Analysts think SNOA stock price could increase by 511%
Nov 21, 2024, 12:26 PM
-5.63%
What does SNOA do
Sonoma Pharmaceuticals, headquartered in Boulder, Colorado, develops hypochlorous acid products for various healthcare applications and went public on January 26, 2007. Their product lineup includes Lumacyn, Regenacyn, and MicrocynAH for skin and wound care.
3 analysts think SNOA stock price will increase by 510.56%. The current median analyst target is $17.34 compared to a current stock price of $2.84. The lowest analysts target is $17.17 and the highest analyst target is $17.85.
📡️ Health Care
Price Target
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.